These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Ziprasidone-induced tardive dyskinesia in a patient without known risk factors. Sinha P; Rao R; Sharan P Natl Med J India; 2007; 20(5):271-2. PubMed ID: 18254531 [No Abstract] [Full Text] [Related]
43. Menstrual disturbance and galactorrhea in people taking conventional antipsychotic medications. Thangavelu K; Geetanjali S Exp Clin Psychopharmacol; 2006 Nov; 14(4):459-60. PubMed ID: 17115873 [TBL] [Abstract][Full Text] [Related]
44. A case report with ziprasidone-induced catatonic symptoms. Markham-Abedi C; McNeely C; de Leon J J Neuropsychiatry Clin Neurosci; 2007; 19(4):476-7. PubMed ID: 18070860 [No Abstract] [Full Text] [Related]
45. Ziprasidone induction of hypomania in depression? Davis R; Risch SC Am J Psychiatry; 2002 Apr; 159(4):673-4. PubMed ID: 11925314 [No Abstract] [Full Text] [Related]
46. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial. Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471 [TBL] [Abstract][Full Text] [Related]
47. Cocaine use as a risk factor for ziprasidone-induced acute dystonia. Duggal HS Gen Hosp Psychiatry; 2007; 29(3):278-9. PubMed ID: 17484950 [TBL] [Abstract][Full Text] [Related]
48. Sudden akathisia after a ziprasidone dose reduction. Oral ET; Altinbas K; Demirkiran S Am J Psychiatry; 2006 Mar; 163(3):546. PubMed ID: 16513883 [No Abstract] [Full Text] [Related]
49. Rapid and Sustained Resolution of Risperidone Associated Hyperprolactinemia and Galactorrhea With Low-Dose Lurasidone. Agapoff JR; Olson DJ; White S; Huynh V J Clin Psychopharmacol; 2020; 40(4):410-412. PubMed ID: 32555004 [No Abstract] [Full Text] [Related]
50. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation. Bentley ML; Biscardi FH; Butcher C; Levitov A Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728 [No Abstract] [Full Text] [Related]
51. Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone. Yang SH; McNeely MJ Am J Psychiatry; 2002 Aug; 159(8):1435. PubMed ID: 12153844 [No Abstract] [Full Text] [Related]
52. Urticaria and angio-oedema due to ziprasidone. Akkaya C; Sarandol A; Aydogan K; Kirli S J Psychopharmacol; 2007 Jul; 21(5):550-2. PubMed ID: 17446198 [TBL] [Abstract][Full Text] [Related]
53. A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed. Barzman DH; DelBello MP; Forrester JJ; Keck PE; Strakowski SM J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):503-9. PubMed ID: 17822344 [TBL] [Abstract][Full Text] [Related]
54. A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder. Das P J Clin Psychopharmacol; 2016 Aug; 36(4):393-4. PubMed ID: 27281388 [No Abstract] [Full Text] [Related]
55. Urinary retention associated with ziprasidone: a case report. Mago R; Chism LM; Pinninti NR; Certa K J Clin Psychiatry; 2008 Mar; 69(3):499-500. PubMed ID: 18402503 [No Abstract] [Full Text] [Related]
59. Acute dystonia after initial doses of ziprasidone: a case report. Yumru M; Savas HA; Selek S; Savas E Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):745-7. PubMed ID: 16580766 [TBL] [Abstract][Full Text] [Related]